Real-time enrollment status for this diffuse cutaneous systemic sclerosis clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 8:57 PM UTC
| NCT Number | NCT07287670 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Cutaneous Systemic Sclerosis |
| Phase | PHASE2 |
| Target Enrollment | 85 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Mediar Therapeutics |
| Last Updated on CT.gov | August 5, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07287670 is currently recruiting participants. This phase2 study for diffuse cutaneous systemic sclerosis is actively seeking new participants at 23 locations across the United States. The study is sponsored by Mediar Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07287670 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07287670 was last updated 3 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.